FermaVar 2.5 Pharmaqo

£75.00

FermaVar 2.5 Pharmaqo contains letrozole, a potent aromatase inhibitor compound for laboratory research applications examining estrogen pathway modulation in cell culture studies.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

FermaVar 2.5 Pharmaqo
FermaVar 2.5 Pharmaqo
£75.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Overview of FermaVar 2.5

FermaVar 2.5 Pharmaqo is a research-grade formulation containing letrozole, a non-steroidal aromatase inhibitor compound extensively investigated in laboratory settings. This third-generation aromatase inhibitor represents one of the most potent selective compounds available for examining estrogen biosynthesis pathways in controlled research environments. Letrozole belongs to the triazole class of compounds and demonstrates exceptional binding affinity for the aromatase enzyme complex (CYP19A1), making it valuable for researchers at Stroid UK Shop studying hormonal pathway modulation mechanisms.

Research Applications

Laboratory investigations with letrozole focus primarily on its mechanism as a competitive aromatase inhibitor, blocking the conversion of androgens to estrogens in peripheral tissues. Research teams examine its effects on estradiol suppression in cell culture models, with studies demonstrating up to 99% reduction in estrogen synthesis at therapeutic concentrations. Endocrinology researchers investigate its reversible binding properties and tissue-specific distribution patterns. Academic institutions studying breast cancer biology frequently examine letrozole’s interactions with estrogen-dependent cell lines. Researchers exploring other drugs often compare letrozole’s selectivity profile against alternative aromatase inhibitors in comparative efficacy studies.

Technical Specifications

Product Specifications for FermaVar 2.5
Parameter Specification
Active Compound Letrozole
Concentration 2.5mg per unit
CAS Number 112809-51-5
Molecular Formula C₁₇H₁₁N₅
Molecular Weight 285.30 g/mol
Manufacturer Pharmaqo
Storage Requirements Room temperature, dry environment
Research Grade Laboratory use only

Researchers comparing letrozole with SARMs often investigate potential interactions, while those studying peptides examine hormonal pathway cross-regulation effects in experimental protocols.

Research Compliance

FermaVar 2.5 Pharmaqo is manufactured strictly for in-vitro research purposes and laboratory applications only. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure proper handling protocols and institutional approval before conducting studies. All investigations should follow established laboratory safety guidelines and regulatory compliance requirements for research-grade chemical compounds.

Related